Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 448, 636-637 (9 August 2007) | doi:10.1038/448636a; Published online 8 August 2007
China tightens up
Top of page
Abstract
Plans to revamp drug regulation in China have yet to convince the sceptics, as Jane Qiu reports.
After a series of scandals that climaxed on 10 July with the execution of Zheng Xiaoyu, former chief of the State Food and Drug Administration (SFDA), China has announced a regime that, it says, will mark a clean start for its approach to drug regulation.The government says that the changes will place the drug-approval system under public scrutiny and avoid misuse of power.
To read this story in full you will need to login or make a payment (see right).